Literature DB >> 15009650

Aggregate formation and synaptic abnormality induced by DSCR1.

Hong Ma1, Hui Xiong, Tong Liu, Lingyan Zhang, Adam Godzik, Zhuohua Zhang.   

Abstract

Aggregation of conformation-abnormal peptides probably plays a key role in the pathogenesis of many neurodegenerative diseases. DSCR1 Down syndrome (DS) critical region 1, was identified from a chromosomal region (21q22.1-q22.2) for the clinical manifestations of DS when an extra-copy is present. We report that expression of DSCR1 in several cell types, including primary neurons, causes microtubule-dependent aggresome-like inclusion body formation. Disease-associated huntingtin (Q148) and ataxin-3 (Q84) co-localize with DSCR1 aggregates. Neurons bearing DSCR1 aggregates show reduced synaptophysin staining in processes. DSCR1 residues 31-90 constitute an aggregation-prone domain that is predicted to form a hydrophobic patch on the protein surface when residues 1-30 are removed. This study identifies a novel function of DSCR1 that may underlie DS neuropathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009650     DOI: 10.1046/j.1471-4159.2003.02294.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  Screening key genes associated with congenital heart defects in Down syndrome based on differential expression network.

Authors:  Shan Yu; Huani Yi; Zhimin Wang; Juan Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.

Authors:  Betty Chan; Garrett Greenan; Frank McKeon; Tom Ellenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

3.  The SCFCdc4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1, an inhibitor of calcineurin.

Authors:  Tsutomu Kishi; Akemi Ikeda; Rina Nagao; Noriko Koyama
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

4.  The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization.

Authors:  S V Kozyrev; M Bernal-Quirós; M E Alarcón-Riquelme; C Castillejo-López
Journal:  Genes Immun       Date:  2011-09-08       Impact factor: 2.676

5.  Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.

Authors:  Xiulian Sun; Yili Wu; Bin Chen; Zhuohua Zhang; Weihui Zhou; Yigang Tong; Junying Yuan; Kun Xia; Hinrich Gronemeyer; Richard A Flavell; Weihong Song
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

6.  Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Authors:  Luzhou Xing; Martha Salas; Hong Zhang; Julia Gittler; Thomas Ludwig; Chyuan-Sheng Lin; Vundavalli V Murty; Wayne Silverman; Ottavio Arancio; Benjamin Tycko
Journal:  Mamm Genome       Date:  2012-10-25       Impact factor: 2.957

7.  RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.

Authors:  Helen Wong; Josien Levenga; Peter Cain; Beverly Rothermel; Eric Klann; Charles Hoeffer
Journal:  Acta Neuropathol       Date:  2015-10-24       Impact factor: 17.088

8.  Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes.

Authors:  María A Rujano; Floris Bosveld; Florian A Salomons; Freark Dijk; Maria A W H van Waarde; Johannes J L van der Want; Rob A I de Vos; Ewout R Brunt; Ody C M Sibon; Harm H Kampinga
Journal:  PLoS Biol       Date:  2006-12       Impact factor: 8.029

9.  RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis.

Authors:  Xiulian Sun; Yili Wu; Bruno Herculano; Weihong Song
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

10.  Covalent NEDD8 conjugation increases RCAN1 protein stability and potentiates its inhibitory action on calcineurin.

Authors:  Eun Hye Noh; Hee Sook Hwang; Hee Sun Hwang; Boram Min; Eunju Im; Kwang Chul Chung
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.